DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding DiaMedica Therapeutics Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 38 | +3 |
| Shares | 4.25M | 168.7K | 3.84M | −240.0K (−5.9%) |
| Value | $11.0M | $435.3K | $10.9M | +$380.5K (+3.6%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 27,619 | $78.4K | 0.00% |
| Jane Street Group, LLC | 23,761 | $67.5K | 0.00% |
| Avantax Advisory Services, Inc. | 12,500 | $35.5K | 0.00% |
| Group One Trading, L.P. | 4,843 | $13.8K | 0.00% |
| Naples Money Management LLC | 3,878 | $11.0K | 0.01% |
| Bank of America Corp | 15 | $43 | 0.00% |
Sold out (3)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| EAM Investors, LLC | 212,512 | $548.3K |
| Marshall Wace, LLP | 26,745 | $69.0K |
| UBS Group AG | 84 | $217 |
Not filed for Q4 2023 yet (1)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Jacob Asset Management of New York LLC | 168,730 | $435.3K |